Ghent University Academic Bibliography

Advanced

Laboratory Detection of the Antiphospholipid Syndrome via Calibrated Automated Thrombography

Katrien Devreese UGent, kathelijne peerlinck, jef arnout and marc hoylaerts (2009) Thrombosis and haemostasis. 101(1). p.185-196
abstract
Lupus anticoagulants (LAC) consist of anti phospholipid antibodies, detected via their anti coagulant properties in vitro. Strong LAC relate to thromboembolic events, a hallmark of the anti-phospholipid syndrome. We have analyzed whether detection of this syndrome would benefit from thrombin generation measurements. Therefore, calibrated automated thrombography was done in normal plasma (n=30) and LAC patient plasma (n=48 non-anticoagulated, n=12 on oral anti coagulants), diluted 1: 1 with a normal plasma pool. The anti-beta(2)-glycoprotein I monoclonal antibody 23H9, with known LAC properties, delayed the lag time and reduced the peak height during thrombin generation induction in normal plasma dose-dependently (0-150 mu g/ml). At variance, LAC patient 1: 1 plasma mixtures manifested variable lag time prolongations and/or peak height reductions. Coupling these two most informative thrombin generation parameters in a peak height/lag time ratio,and upon normalization versus the normal plasma pool, this ratio distributed normally and was reduced in the plasma mixtures, for 59/60 known LAC plasmas. The normalized peak height/lag time ratio correlated well with the normalized dilute prothrombin time,diluted Russell's viper venom time and silica clotting time, measured in 1: 1 plasma mixtures (correlation coefficients 0.59-0.72). The anticoagulant effects of activated protein C (0-7.5 nM) or 23H9 (0-150 mu g/ml), spiked in the 1: 1 LAC plasma mixtures were reduced for the majority of patients, compatible with functional competition between patient LAC and activated protein C and LAC and 23H9, respectively. Hence,the normalized thrombin gene ration-derived peak height/lag time ratio identifies LAC in plasma with high sensitivity in a single assay, irrespective of the patient's treatment with oral anticoagulants.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
ANTICARDIOLIPIN ANTIBODIES, THROMBIN GENERATION, ACQUIRED-RESISTANCE, IGG ANTIBODIES, BETA(2)-GLYCOPROTEIN-I, BETA-2-GLYCOPROTEIN-I, PROTHROMBIN, PLASMA, ACTIVATED PROTEIN-C, LUPUS ANTICOAGULANTS, prothrombin, antibodies, alpha(2)-glycoprotein I, lupus anticoagulants, Thrombosis
journal title
Thrombosis and haemostasis
Thromb. Haemost.
volume
101
issue
1
pages
185 - 196
publisher
Schattauer
place of publication
Stuttgart
Web of Science type
Article
Web of Science id
000262626700030
JCR category
PERIPHERAL VASCULAR DISEASE
JCR impact factor
4.451 (2009)
JCR rank
10/60 (2009)
JCR quartile
1 (2009)
ISSN
0340-6245
DOI
10.1160/TH08-06-0393
language
English
UGent publication?
yes
classification
A1
copyright statement
I have transferred the copyright for this publication to the publisher
id
877301
handle
http://hdl.handle.net/1854/LU-877301
date created
2010-02-23 15:59:16
date last changed
2017-01-02 09:55:47
@article{877301,
  abstract     = {Lupus anticoagulants (LAC) consist of anti phospholipid antibodies, detected via their anti coagulant properties in vitro. Strong LAC relate to thromboembolic events, a hallmark of the anti-phospholipid syndrome. We have analyzed whether detection of this syndrome would benefit from thrombin generation measurements. Therefore, calibrated automated thrombography was done in normal plasma (n=30) and LAC patient plasma (n=48 non-anticoagulated, n=12 on oral anti coagulants), diluted 1: 1 with a normal plasma pool. The anti-beta(2)-glycoprotein I monoclonal antibody 23H9, with known LAC properties, delayed the lag time and reduced the peak height during thrombin generation induction in normal plasma dose-dependently (0-150 mu g/ml). At variance, LAC patient 1: 1 plasma mixtures manifested variable lag time prolongations and/or peak height reductions. Coupling these two most informative thrombin generation parameters in a peak height/lag time ratio,and upon normalization versus the normal plasma pool, this ratio distributed normally and was reduced in the plasma mixtures, for 59/60 known LAC plasmas. The normalized peak height/lag time ratio correlated well with the normalized dilute prothrombin time,diluted Russell's viper venom time and silica clotting time, measured in 1: 1 plasma mixtures (correlation coefficients 0.59-0.72). The anticoagulant effects of activated protein C (0-7.5 nM) or 23H9 (0-150 mu g/ml), spiked in the 1: 1 LAC plasma mixtures were reduced for the majority of patients, compatible with functional competition between patient LAC and activated protein C and LAC and 23H9, respectively. Hence,the normalized thrombin gene ration-derived peak height/lag time ratio identifies LAC in plasma with high sensitivity in a single assay, irrespective of the patient's treatment with oral anticoagulants.},
  author       = {Devreese, Katrien and peerlinck, kathelijne and arnout, jef and hoylaerts, marc},
  issn         = {0340-6245},
  journal      = {Thrombosis and haemostasis},
  keyword      = {ANTICARDIOLIPIN ANTIBODIES,THROMBIN GENERATION,ACQUIRED-RESISTANCE,IGG ANTIBODIES,BETA(2)-GLYCOPROTEIN-I,BETA-2-GLYCOPROTEIN-I,PROTHROMBIN,PLASMA,ACTIVATED PROTEIN-C,LUPUS ANTICOAGULANTS,prothrombin,antibodies,alpha(2)-glycoprotein I,lupus anticoagulants,Thrombosis},
  language     = {eng},
  number       = {1},
  pages        = {185--196},
  publisher    = {Schattauer},
  title        = {Laboratory Detection of the Antiphospholipid Syndrome via Calibrated Automated Thrombography},
  url          = {http://dx.doi.org/10.1160/TH08-06-0393},
  volume       = {101},
  year         = {2009},
}

Chicago
Devreese, Katrien, kathelijne peerlinck, jef arnout, and marc hoylaerts. 2009. “Laboratory Detection of the Antiphospholipid Syndrome via Calibrated Automated Thrombography.” Thrombosis and Haemostasis 101 (1): 185–196.
APA
Devreese, K., peerlinck, kathelijne, arnout, jef, & hoylaerts, marc. (2009). Laboratory Detection of the Antiphospholipid Syndrome via Calibrated Automated Thrombography. Thrombosis and haemostasis, 101(1), 185–196.
Vancouver
1.
Devreese K, peerlinck kathelijne, arnout jef, hoylaerts marc. Laboratory Detection of the Antiphospholipid Syndrome via Calibrated Automated Thrombography. Thrombosis and haemostasis. Stuttgart: Schattauer; 2009;101(1):185–96.
MLA
Devreese, Katrien, kathelijne peerlinck, jef arnout, et al. “Laboratory Detection of the Antiphospholipid Syndrome via Calibrated Automated Thrombography.” Thrombosis and haemostasis 101.1 (2009): 185–196. Print.